Huiling Zheng
Beijing, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Targeting KRAS: from metabolic regulation to cancer treatment.
Journal: Molecular cancer
Published: September 06, 2024
AUF1-mediated inhibition of autophagic lysosomal degradation contributes to CagA stability and Helicobacter pylori-induced inflammation.
Journal: Gut microbes
Published: July 28, 2024
Effects and mechanisms of Helicobacter pylori on cancers development and immunotherapy.
Journal: Frontiers in immunology
Published: July 23, 2024
CMTM4 inhibits gastric tumorigenesis and metastasis.
Journal: Journal of gastrointestinal oncology
Published: June 20, 2024
Cmtm4 deficiency exacerbates colitis by inducing gut dysbiosis and S100a8/9 expression.
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: March 26, 2024
The A1762T/G1764A mutations enhance HBV replication by alternating viral transcriptome.
Journal: Journal of medical virology
Published: April 11, 2023
RNA binding protein TIAR modulates HBV replication by tipping the balance of pgRNA translation.
Journal: Signal transduction and targeted therapy
Published: January 30, 2023
The tibetan medicine Zuozhu-Daxi can prevent Helicobacter pylori induced-gastric mucosa inflammation by inhibiting lipid metabolism.
Journal: Chinese medicine
Published: September 01, 2022
Effect of Helicobacter pylori on immunotherapy is gaining more attention.
Journal: Helicobacter
Published: July 11, 2022
Solely HBsAg intrauterine exposure accelerates HBV clearance by promoting HBs-specific immune response in the mouse pups.
Journal: Emerging microbes & infections
Published: May 11, 2022
COVID-19 pharmacological research trends: a bibliometric analysis.
Journal: Intelligent medicine
Published: April 29, 2022
Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses.
Journal: Frontiers in immunology
Published: April 19, 2022
Last Updated: 09/26/2026